Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Epidermolysis Bullosa (EB)”

28 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 28 results

Post-approval studies (Phase 4)Active Not RecruitingNCT07596927
What this trial is testing

Curcumin-Based Photodynamic Therapy in Epidermolysis Bullosa: Wound Healing, Quality of Life, and Salivary Biomarkers

Who this might be right for
Epidermolysis Bullosa (EB)Epidermolysis Bullosa DystrophicaEpidermolysis Bullosa Acquisita
Universidade Ceuma 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07011589
What this trial is testing

Targeting Collagen VII Antibodies in Bullous Diseases Using Efgartigimod IV (VYVGART)

Who this might be right for
Epidermolysis Bullosa (EB)Epidermolysis Bullosa AcquisitaRecessive Dystrophic Epidermolysis Bullosa+1 more
M. Peter Marinkovich 18
Early research (Phase 1)Active Not RecruitingNCT06713434
What this trial is testing

Pilot Study of ELK-003 Eye Drops for Treating Ocular Manifestations of Epidermolysis Bullosa

Who this might be right for
Junctional Epidermolysis BullosaEpidermolysis Bullosa (EB)Dystrophic Epidermolysis Bullosa+1 more
Fundación DEBRA Chile, Niños Piel de Cristal 20
Large-scale testing (Phase 3)Active Not RecruitingNCT05464381
What this trial is testing

Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of Epidermolysis Bullosa (Phase III, Cross-over)

Who this might be right for
Epidermolysis Bullosa
RHEACELL GmbH & Co. KG 91
Large-scale testing (Phase 3)Not Yet RecruitingNCT07482813
What this trial is testing

An Open Label Extension Safety Study to Evaluate SD-101 in Epidermolysis Bullosa

Who this might be right for
Epidermolysis Bullosa (EB)
Paradigm Therapeutics 80
Not applicableTemporarily pausedNCT04031469
What this trial is testing

A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease

Who this might be right for
Gut MicrobiomeGastrointestinal MicrobiomeAutism+77 more
ProgenaBiome 1,000
Testing effectiveness (Phase 2)Study completedNCT03389308
What this trial is testing

Long Term Open-label Study Evaluating Safety of Diacerein 1% Ointment Topical Formulation in Subjects With Epidermolysis Bullosa Simplex

Who this might be right for
Epidermolysis BullosaEpidermolysis Bullosa Simplex
Castle Creek Pharmaceuticals, LLC 51
Testing effectiveness (Phase 2)Study completedNCT01033552
What this trial is testing

Biochemical Correction of Severe EB by Allo HSCT and "Off-the-shelf" MSCs

Who this might be right for
Epidermolysis Bullosa
Masonic Cancer Center, University of Minnesota 32
Not applicableStudy completedNCT03158662
What this trial is testing

Survey to Identify Burdens and Unmet Needs of Patients With Epidermolysis Bullosa

Who this might be right for
Epidermolysis Bullosa
Amicus Therapeutics 150
Testing effectiveness (Phase 2)Study completedNCT02582775
What this trial is testing

MT2015-20: Biochemical Correction of Severe EB by Allo HSCT and Serial Donor MSCs

Who this might be right for
Epidermolysis Bullosa
Masonic Cancer Center, University of Minnesota 17
Large-scale testing (Phase 3)Active Not RecruitingNCT05838092
What this trial is testing

Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of Epidermolysis Bullosa (Phase III)

Who this might be right for
Epidermolysis Bullosa
RHEACELL GmbH & Co. KG 9
Testing effectiveness (Phase 2)Study completedNCT03529877
What this trial is testing

Allogeneic ABCB5-positive Stem Cells for Treatment of Epidermolysis Bullosa

Who this might be right for
Recessive Dystrophic Epidermolysis Bullosa
RHEACELL GmbH & Co. KG 16
Testing effectiveness (Phase 2)Looking for participantsNCT06594393
What this trial is testing

TCP-25 Gel in Patients With Epidermolysis Bullosa, STEP-study

Who this might be right for
Epidermolysis Bullosa (EB)Dystrophic Epidermolysis BullosaJunctional Epidermolysis Bullosa
Xinnate AB 32
Testing effectiveness (Phase 2)Looking for participantsNCT06834035
What this trial is testing

Targeting Collagen VII Antibodies With IV IgG in Dystrophic Epidermolysis Bullosa

Who this might be right for
Epidermolysis BullosaEpidermolysis Bullosa AcquisitaDystrophic Epidermolysis Bullosa+1 more
M. Peter Marinkovich 8
Early research (Phase 1)Study completedNCT03472287
What this trial is testing

To Evaluate the Pharmacokinetic of Diacerein and Rhein After Maximum Use in Patients With Epidermolysis Bullosa (EB)

Who this might be right for
Epidermolysis Bullosa (EB)Epidermolysis Bullosa SimplexDystrophic Epidermolysis Bullosa+1 more
Castle Creek Pharmaceuticals, LLC 11
Post-approval studies (Phase 4)Not Yet RecruitingNCT07240649
What this trial is testing

Outcomes From Hyperbaric Oxygen (HBO2) Treatment for Emerging Indications

Who this might be right for
Post-COVID-19 ConditionUlcerative ColitisCrohn Disease+38 more
Jay C. Buckey Jr. 100
Testing effectiveness (Phase 2)Study completedNCT04644627
What this trial is testing

Topical Gentamicin Nonsense Suppression Therapy of EB

Who this might be right for
Epidermolysis Bullosa
Oslo University Hospital 4
Not applicableLooking for participantsNCT07312513
What this trial is testing

Multicenter, Randomized, Non-inferiority Study to Compare the Performance and Safety of Debrisoft® Duo With Debrisoft® Pad in the Debridement of Wounds

Who this might be right for
Diabetic UlcersArterial UlcersVenous Ulcers+6 more
Lohmann & Rauscher 104
Testing effectiveness (Phase 2)Study completedNCT05143190
What this trial is testing

Extension Study to PTR-01-002 (A Study in Recessive Dystrophic Epidermolysis Bullosa (RDEB) Patients Previously Treated With PTR-01)

Who this might be right for
Recessive Dystrophic Epidermolysis Bullosa
Phoenix Tissue Repair, Inc. 2
Testing effectiveness (Phase 2)Study completedNCT02654483
What this trial is testing

Neurokinin-1 Receptor Antagonist for the Treatment of Itch in EB Patients

Who this might be right for
Epidermolysis BullosaPruritus
Jean Yuh Tang 14
Load More Results